Wilder Named OPASI Division Director
Dr. Elizabeth L. Wilder Appointed Director of OPASIís Division of Strategic Coordination
Elizabeth L. Wilder, Ph.D., has been appointed director of the Division
of Strategic Coordination in the Office of Portfolio Analysis and
Strategic Initiatives (OPASI). Dr. Wilder served as division director
in an acting capacity for the last year and a half and officially
assumed the post in August.
National Institutes of Health (NIH) Director, Elias A. Zerhouni, M.D., established OPASI to identify impor≠tant areas of emerging scientific opportunities or rising public health challenges and to help accelerate investments in these areas to make sure new ideas have a chance to develop. OPASI also is dedicated to developing new resources and tools to support the management and assessment of the NIH scientific portfolio.
OPASIís Division of Strategic Coordination provides increased opportunity for trans-NIH dialogue, decision-making and funding for scien≠tific programs that are intended to foster innovation and catalyze research broadly. It is the Division within OPASI that manages the NIH Common Fund (http://nihroadmap.nih.gov/commonfund.asp) and oversees the NIH Roadmap for Medical Research (http://nihroadmap.nih.gov/). Other Divisions of OPASI are involved in analysis of the NIH funding portfolio and evaluation of trans-NIH programs.
"I am delighted to have Dr. Wilder in the position of division director,"
said Zerhouni. "She will have a significant impact at NIH in her work addressing
critical research efforts in intersecting areas of NIH priorities."
Wilder graduated from Hendrix College in Conway, Arkansas in 1984, received
her Ph.D. from Northwestern University in 1989, and trained as a postdoctoral
fellow at Harvard Medical School. In her last position before coming to NIH,
she served on the faculty in the Department of Cell and Developmental Biology
at the University of Pennsylvania School of Medicine. She started at the NIH
in 2002 as a Program Director at the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK).
"We are extremely fortunate to have Dr. Wilder join us in a permanent capacity,"
said Alan M. Krensky, M.D., Director of OPASI. "She will play a key leadership
role as the Division of Strategic Coordination guides the NIH Roadmap Initiatives
and continues to support NIH in efforts to identify cross-cutting, potentially
transformative areas of health research.Ē
Wilder has been engaged in Trans-NIH initiatives since coming to the NIH. Most recently she served as co-chair of the Multiple Principal Investigator Policy Implementation Committee and as coordinator for the NIH Roadmap Interdisciplinary Research Working Group. In addition to her acting role in the Division of Strategic Coordination over the past year, she has provided central leadership to OPASI as Acting Associate Director of the Office. Wilder becomes OPASIís first director of strategic coordination.
The NIH Roadmap for Medical Research, launched in 2004, is a series of initiatives
designed to address fundamental knowledge gaps, develop transformative tools
and technologies, and/or foster innovative approaches to complex problems.
Funded through the NIH Common Fund, these programs cut across the missions
of individual NIH Institutes and Centers (ICs) and are intended to accelerate
the translation of research to improvements in public health. OPASI, in collaboration
with all NIH ICs, oversees programs funded by the Common Fund. Additional information
about the NIH Roadmap and Common Fund can be found at (http://nihroadmap.nih.gov/)
. Additional information about OPASI can be found at
The Office of the Director, the central office at NIH, is responsible for
setting policy for NIH, which includes 27 Institutes and Centers. This involves
planning, managing, and coordinating the programs and activities of all NIH
components. The Office of the Director also includes program offices which
are responsible for stimulating specific areas of research throughout NIH.
Additional information is available at (http://www.nih.gov/icd/od/).
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.